Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Stites, T."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferrari, M.D., Reuter, U., Goadsby, P.J., Lima, G.P.D., Mondal, S., Wen, S.H., Tenenbaum, N., Pandhi, S., Lanteri-Minet, M., Stites, T.
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry. BMJ PUBLISHING GROUP
Journal of Neurology, Neurosurgery and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry
Objective To evaluate individual and group long-term efficacy and safety of erenumab in individuals with episodic migraine (EM) for whom 2-4 prior preventatives had failed.Methods Participants completing the 12-week double-blind treatment phase (DBTP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::943e12679abb8485e18cbf8077c27271
https://doi.org/10.1136/jnnp-2021.327480
https://doi.org/10.1136/jnnp-2021.327480
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chitnis, T, Arnold, Dl, Banwell, B, Brück, W, Ghezzi, A, Giovannoni, G, Greenberg, B, Krupp, L, Rostásy, K, Tardieu, M, Waubant, E, Wolinsky, Js, Bar-Or, A, Stites, T, Chen, Y, Putzki, N, Merschhemke, M, Gärtner, Collaborators (85): Kornberg A, J, Bajer-Kornek, B, Likhachev, S, Pereira Gomes Neto, A, Diniz, D, Paz, J, Alvarenga, R, Bojinova-Tchamova, V, Mah, J, Venkateswaran, S, Hafner, K, Gross-Paju, K, Brochet, B, Cheuret, E, Rivier, F, Deiva, K, Milh, M, Blaschek, A, Trollmann, R, Korinthenberg, R, Luecke, T, Ziemssen, T, Pozzilli, C, Patti, F, Comi, G, Marfia, G, Grimaldi, L, Trojano, M, Zaffaroni, M, Capra, R, Brescia Morra, V, Rozentals, G, Laurynaitiene, J, Vaiciene-Magistris, N, Castro Farfan, F, Quinones, S, Steinborn, B, Ujma-Czapska, B, Stasiolek, M, Jasinski, M, Craiu, D, Boyko, A, Kairbekova, E, Khabirov, F, Kuzenkova, L, Malkova, N, Nikolic, D, Jancic, J, Gebauer-Bukurov, K, Payerova, J, Gascon Jiménez, F, Izquierdo Ayuso, G, Mendibe Bilbao, M, Hintzen, R, Fernandez Sanchez VE, Meca Lallana, V, Montalban Gairin, X, Nordborg, K, Anlar, B, Yalcinkaya, C, Gucuyener, K, Terzi, M, Ozakbas, S, Yilmaz, U, Makedonska, I, Prokopenko, K, Tantsura, L, Moskovko, S, Kobys, T, Muratova, T, Nehrych, T, Prykhodko, T, Hemingway, C, Wassmer, E, Shetty, J, Desai, J, Waldman, A, Chinea Martinez, A, Ness, J, Rammohan, K, Lloyd, M, Williams, M, Ayala, R, Davis, R, Bhise, V
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (11), pp.1017--1027. ⟨10.1056/NEJMoa1800149⟩
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (11), pp.1017--1027. ⟨10.1056/NEJMoa1800149⟩
International audience; BACKGROUND: Treatment of patients younger than 18 years of age with multiple sclerosis has not been adequately examined in randomized trials. We compared fingolimod with interferon beta-1a in this population. METHODS: In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeba88a713e7b1344a7c44bdeb4a8f5e
http://hdl.handle.net/11573/1225838
http://hdl.handle.net/11573/1225838
Autor:
Khatri, B, Barkhof, F, Comi, G, Hartung, Hp, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang auberson, L, Francis, G, Cohen, Ja, Cohen, J, Easton, Jd, Calandra, T, Dimarco, J, Hudson, L, Kesselring, J, Laupacis, A, Temkin, N, Weinshenker, B, Zarbin, M, Poppe, P, Luetic, G, Cristiano, E, Caceres, F, Garcea, O, Correale, J, Ballario, C, Piedrabuena, R, Pollard, J, Beran, R, Hodgkinson, S, Schwartz, R, Heard, R, King, J, Butzkueven, H, Maida, Em, Vass, K, Franta elmer, C, Berger, T, Aichner, F, Ladurner, G, Bissay, V, Sindic, C, D'Hooghe, M, Mulleners, E, Damasceno, B, Barreira, A, Naylor, R, Alvarenga, R, Bacellar, A, Haussen, S, Duquette, P, Antel, J, Lamontagne, A, Grand'Maison, F, Freedman, M, Christie, S, O'Connor, P, Vorobeychik, G, Devonshire, V, Ramadan, M, Hamdy, S, Reda, E, Hashem, S, Fouad, M, Lebrun frenay, C, Clanet, M, Brochet, B, Debouverie, M, Heinzlef, O, Ziemssen, T, Koehler, W, Tiel wilck, K, Bachus, R, Altmann, N, Faiss, J, Baum, K, Dressel, A, Luckner, K, Ebke, M, Stangel, M, Diener, Hc, Bethke, F, Limmroth, V, Maschke, M, Thoemke, F, Reifschneider, G, Diehm, R, Wildemann, B, Melms, A, Rauer, S, Karlbauer, G, Berthele, A, Lang, M, Tumani, H, Krauseneck, P, Klein, M, Papadimitriou, A, Karageorgiou, K, Liakopoulos, D, Tascos, N, Plaitakis, A, Papathanasopoulos, P, Panczel, G, Jakab, G, Csiba, L, Komoly, S, Csanyi, A, Bartos, L, Centonze, D, Pozzilli, C, Marrosu, Mg, Bertolotto, A, Mancardi, GIOVANNI LUIGI, Scarpini, E, Protti, A, Ghezzi, A, Capra, R, Bergamaschi, R, Gallo, P, Stecchi, S, Montanari, E, Tola, Mr, Amato, Mp, Silvestrini, M, Lugaresi, A, Trojano, M, Morra, Vb, Ruggieri, S, Patti, F, Kim, Sm, Lee, Kh, Kim, Hj, Park, Sp, Ginestal, R, Salgado, Av, Fontoura, P, Cunha, L, Sousa, L, Mj, Sá, Pedrosa, R, Arbizu, T, Arroyo, R, Merino, Ja, Fernandez, O, Izquierdo, G, Casanova, B, Antigüedad, A, Goebels, N, Young, C, Lee, M, Chaudhuri, A, Nicholas, R, Martinez, Ac, Preiningerova, J, Greco, D, Gross, J, Newman, S, Mitchell, G, Pawar, G, Freedman, Sm, Kaufman, M, Absher, J, Kantor, D, Ayala, R, Honeycutt, W, Shafer, S, Steingo, B, Delgado, S, Cascione, M, Brock, C, Keegan, A, Laganke, C, Hunter, S, Wilson, E, Mazhari, A, Bauer, W, Singer, B, Lynch, S, Rowe, V, Hutton, G, Gazda, S, Dihenia, B, Campagnolo, D, Chippendale, T, Ash, P, Jung, L, Olek, M.
Publikováno v:
Lancet Neurology, 10(6), 520-529. Lancet Publishing Group
Khatri, B, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang-Auberson, L, Francis, G & Cohen, J A 2011, ' Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study ', Lancet Neurology, vol. 10, no. 6, pp. 520-529 . https://doi.org/10.1016/S1474-4422(11)70099-0
The Lancet Neurology, Vol. 10, no. 6, p. 520-529 (2011)
Khatri, B, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang-Auberson, L, Francis, G & Cohen, J A 2011, ' Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study ', Lancet Neurology, vol. 10, no. 6, pp. 520-529 . https://doi.org/10.1016/S1474-4422(11)70099-0
The Lancet Neurology, Vol. 10, no. 6, p. 520-529 (2011)
In a 12-month phase 3 study in patients with relapsing-remitting multiple sclerosis (RRMS), TRANSFORMS, fingolimod showed greater efficacy on relapse rates and MRI outcomes compared with interferon beta-1a. We had two aims in our extension: to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b6b2b6d615d53be257bbae8c177cf2
https://research.vumc.nl/en/publications/3df38b4b-0d43-4821-a26d-c5a1be088332
https://research.vumc.nl/en/publications/3df38b4b-0d43-4821-a26d-c5a1be088332
Autor:
Cohen, J, Barkhof, F, Comi, G, Hartung, H, Khatri, B, Montalban, X, Pelletier, J, Capra, R, Gallo, P, Izquierdo, G, Tiel Wilck, K, de Vera, A, Jin, J, Stites, T, Wu, S, Aradhye, S, Kappos, L, TRANSFORMS Study Group, Contributor, Centonze, D
Publikováno v:
Cohen, J A, Barkhof, F, Comi, G, Hartung, H P, Khatri, B O, Montalban, X, Pelletier, J, Capra, R, Gallo, P, Izquierdo, G, Tiel-Wilck, K, de Vera, A, Jin, J, Stites, T, Wu, S, Aradhye, S & Kappos, L 2010, ' Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis ', New England Journal of Medicine, vol. 362, no. 5, pp. 402-415 . https://doi.org/10.1056/NEJMoa0907839
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2010, 362 (5), pp.402-415
New England Journal of Medicine, Vol. 362, no.5, p. 402-15 (février 2010)
New England Journal of Medicine, 2010, 362 (5), pp.402-415
New England Journal of Medicine, 362(5), 402-415. Massachussetts Medical Society
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2010, 362 (5), pp.402-415
New England Journal of Medicine, Vol. 362, no.5, p. 402-15 (février 2010)
New England Journal of Medicine, 2010, 362 (5), pp.402-415
New England Journal of Medicine, 362(5), 402-415. Massachussetts Medical Society
1533-4406 (Electronic) 0028-4793 (Linking) Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't; BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d984280e2c1921b91d36d44e8f139936
Publikováno v:
Clinical & Experimental Immunology. Jan1973, Vol. 13 Issue 1, p21-28. 8p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cohen, J., Barkhof, F., Comi, G., Hartung, H.P., Kappos, L., Khatri, B., Montalban, X., Pelletier, J., Stites, T., Wu, S., Jin, J., Eckert, B.
Publikováno v:
Neurology, 74(9), A543-A544. Lippincott Williams and Wilkins
Cohen, J, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Khatri, B, Montalban, X, Pelletier, J, Stites, T, Wu, S, Jin, J & Eckert, B 2010, ' Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS) ', Neurology, vol. 74, no. 9, pp. A543-A544 .
Cohen, J, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Khatri, B, Montalban, X, Pelletier, J, Stites, T, Wu, S, Jin, J & Eckert, B 2010, ' Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS) ', Neurology, vol. 74, no. 9, pp. A543-A544 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b10e7e6121c421d2737ce07ec2c216aa
https://research.vumc.nl/en/publications/34718909-9bf2-4b43-9354-a1b4ca087d40
https://research.vumc.nl/en/publications/34718909-9bf2-4b43-9354-a1b4ca087d40